Breast cancer therapy--the price of success

Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944).

Breast cancer research and treatment·2008

Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2005

Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2003

Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662.

Clinical cancer research : an official journal of the American Association for Cancer Research·2001

HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000

Purchasing oncology services. Kerr L. White Institute/American Cancer Society Task Force on Purchasing Oncology Services.

Cancer·2000

Clinical Uses of Common Genetic Variants Associated with Common Diseases.

The New England journal of medicine·2026

Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome.

The New England journal of medicine·2026

Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma.

The New England journal of medicine·2026

Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis.

The New England journal of medicine·2026

Adult-Onset Central Nervous System Erdheim-Chester Disease Successfully Treated With Cladribine and Cytarabine: Case Report and Literature Review.

EJHaem·2026

Management of ectopic Cushing syndrome in medullary thyroid carcinoma: from case reports to systematic literature review.

Frontiers in endocrinology·2026

Treatment switching in oncology evidence synthesis: a systematic review of meta-analytical practices incorporating time-dependent confounding, censoring bias, and patient-level variability.

Dialogues in health·2026

Association of opioid-based and opioid-free multimodal analgesia with hospital length of stay and postoperative pain in outpatient aesthetic plastic surgery: a retrospective cohort study.

JPRAS open·2026

Catatonic Features That May Be Mistaken for Worsening Autism Show Treatment-Associated Improvement: Implications for Later Regression.

medRxiv : the preprint server for health sciences·2026

Integrative pipeline to profile and target endocrine therapy-insensitive cell populations in ER+ breast cancer.

bioRxiv : the preprint server for biology·2026

Related Experiment Videos

Breast cancer therapy--the price of success

Related Concept Videos

Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944).

Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13.

Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.

Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662.

HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer.

Purchasing oncology services. Kerr L. White Institute/American Cancer Society Task Force on Purchasing Oncology Services.

Clinical Uses of Common Genetic Variants Associated with Common Diseases.

Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome.

Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma.

Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis.

Adult-Onset Central Nervous System Erdheim-Chester Disease Successfully Treated With Cladribine and Cytarabine: Case Report and Literature Review.

Management of ectopic Cushing syndrome in medullary thyroid carcinoma: from case reports to systematic literature review.

Treatment switching in oncology evidence synthesis: a systematic review of meta-analytical practices incorporating time-dependent confounding, censoring bias, and patient-level variability.

Association of opioid-based and opioid-free multimodal analgesia with hospital length of stay and postoperative pain in outpatient aesthetic plastic surgery: a retrospective cohort study.

Catatonic Features That May Be Mistaken for Worsening Autism Show Treatment-Associated Improvement: Implications for Later Regression.

Integrative pipeline to profile and target endocrine therapy-insensitive cell populations in ER+ breast cancer.

Related Experiment Videos

Breast cancer therapy--the price of success

Related Concept Videos

Related Articles